We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 247

Patent not eligible for listing: patent claiming one medicinal ingredient,but directed to a fixed-dose combination of medicines

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 15 2014

This was an appeal from two decisions for three proceedings before Prothonotary Milczynski, in which she determined that a patent could not be listed

Court determines beneficial ownership of several patents as part of action for wrongful conduct

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 15 2014

This was an action by the Plaintiff for relief arising from the allegedly wrongful conduct of the Defendant Li. The Plaintiff claimed that Li

Federal Court overturns Prothonotary’s order striking paragraphs from Defence

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 7 2014

This was a motion appealing the order of a prothonotary in the context of a patent infringement case. In the order appealed from, the Prothonotary

Documents included in joint book for trial should be exhibits for appeal

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • June 11 2012

The issue to be determined relates to the contents of the appeal books

Court bifurcates determination of Start Date for section 8 action

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • May 30 2014

This is an action commenced pursuant to section 8 of the Patented Medicines (Notice of Compliance) Regulations. Pfizer counterclaimed against Apotex

Patent found invalid on basis of lack of utility, sound prediction and obviousness

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 3 2012

This decision relates to an impeachment action and an infringement action that were consolidated

Pfizer Canada v. Genpharm ULC and Mylan Pharmaceuticals et al

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 5 2010

This is a motion brought in the context of a proceeding under the Patented Medicines (Notice of Compliance) Regulations (Regulations) pursuant to Section 6(5)(b) of the Regulations

Question remitted to the court a second time for redetermination

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 25 2012

The Court of Appeal remitted a case to the Court, requiring the Court to redetermine whether Corlac had infringed a method claim by inducement

Patent Appeal Board has jurisdiction to consider new defects introduced by the applicants amendments made in response to a final action

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 26 2012

The application relates to a dual balloon catheter

Anticipation and obviousness found

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • December 12 2011

At trial, the Defendants alleged anticipation, obviousness and lack of utility